Mesoblast | MSB - Cash And Equivalent

Stock Price
2.39
Daily Change
-0.08 -3.24%
Monthly
-12.77%
Yearly
-18.15%
Q1 Forecast
2.48

Mesoblast reported $62.56M in Cash and Equivalent for its fiscal semester ending in June of 2024.





Cash And Equivalent Change Date
Avita Medical AUD 12.22M 1.83M Jun/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
Sonic Healthcare AUD 645M 25.39M Jun/2024
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Telix Pharmaceuticals AUD 710.35M 587.11M Dec/2024